Evidence map›Paper›PMID 32247924›Full record

ArticleMolecular metabolism2020

Characterizing pancreatic β-cell heterogeneity in the streptozotocin model by single-cell transcriptomic analysis.

Ye Feng, Wei-Lin Qiu, Xin-Xin Yu, Yu Zhang, Mao-Yang He, Lin-Chen Li, Li Yang, Weiyi Zhang, Michael Franti, Junqing Ye and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Ye FengMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; PKU-Tsinghua-NIBS Graduate Program, China.
Wei-Lin QiuMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; PKU-Tsinghua-NIBS Graduate Program, China.
Xin-Xin YuMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Yu ZhangMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Mao-Yang HeMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; PKU-Tsinghua-NIBS Graduate Program, China.
Lin-Chen LiMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Li YangMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Weiyi ZhangDepartment of Research Beyond Borders, Boehringer Ingelheim (China) Investment Co., Beijing, China.
Michael FrantiDepartment of Research Beyond Borders, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.
Junqing YeDepartment of Research Beyond Borders, Boehringer Ingelheim (China) Investment Co., Beijing, China. Electronic address: junqing.ye@boehringer-ingelheim.com.
Joerg D HoeckDepartment of Research Beyond Borders, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. Electronic address: joerg.hoeck@boehringer-ingelheim.com.
Cheng-Ran XuMinistry of Education Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, China. Electronic address: cxu@pku.edu.cn.
Peking University · CNKing Center · USBoehringer Ingelheim (China) · CNBoehringer Ingelheim (France) · FRBoehringer Ingelheim (United States) · USCenter for Life Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe streptozotocin (STZ) model is widely used in diabetes research. However, the cellular and molecular states of pancreatic endocrine cells in this model remain unclear. This study explored the molecular characteristics of islet cells treated with STZ and re-evaluated β-cell dysfunction and regeneration in the STZ model.

methodsWe performed single-cell RNA sequencing of pancreatic endocrine cells from STZ-treated mice. High-quality sequencing data from 2,999 cells were used to identify clusters via Louvain clustering analysis. Principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), uniform manifold approximation and projection (UMAP), force-directed layout (FDL), and differential expression analysis were used to define the heterogeneity and transcriptomic changes in islet cells. In addition, qPCR and immunofluorescence staining were used to confirm findings from the sequencing data.

resultsUntreated β-cells were divided into two populations at the transcriptomic level, a large high-Glut2 expression (Glut2

conclusionsWe identified the heterogeneity of β-cells in both physiological and pathological conditions. However, we did not observe conversion of Glut2

Indexed as

AnimalsBlood GlucoseDiabetes Mellitus, ExperimentalGene ExpressionGene Expression ProfilingGene Expression RegulationGlucagon-Secreting CellsGlucoseGlucose Transporter Type 2HumansInsulinInsulin-Secreting CellsIslets of LangerhansMaleMiceMice, TransgenicBlood GlucoseGlucoseGlucose Transporter Type 2InsulinSlc2a2 protein, mouseStreptozocinDiabetesSingle-cell RNA-sequencingStreptozotocin (STZ) modelTrans-differentiationβ-cell heterogeneity

Identifiers

PMID32247924
PMCPMC7184252
OpenAlexW3014806766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.